Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Medical research

Testing & Processing Cannabinoid analysis

A View From the Biosynthetic Bridge

What are biosynthetic cannabinoids? And what do they mean for pharma?

Business & Profession Business

Smashing the Stigma with Science

Neil Mahapatra gives the story behind a partnership with Oxford University to develop cannabinoid medicines

Research & Development Medical research

An Alternative Approach

Boosting the body's built-in cannabinoid signaling receptors

Testing & Processing Cannabinoid analysis

Cannabis Complex

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

Research & Development Pharmaceutical

Pharma's Great Green Rush

A resurgence in interest from medicine makers is opening up new avenues in cannabinoid research

Business & Profession Medical research

Opportunity Knocks

To understand the true potential of cannabis we need rigorous, unbiased research

Research & Development Medical research

Inflammatory News

New research on endocannabinoids sheds light on how they fight inflammation

Research & Development Addiction

Treating Opioid Addiction with CBD? TBD...

Could cannabis come to the rescue in the midst of an “opioid epidemic”?

Research & Development Pharmaceutical

Breaking with Tradition

What does legalizing medical cannabis mean for conventional pharmaceuticals?

Business & Profession Profession

Medical Cannabis Campaigner

Sitting Down With... Tracy Ryan, CEO and founder of CannaKids.

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register